focus trial semaglutide can raise liver enzymes The effect of on in subjects with obesity and elevated alanine aminotransferase: data from a randomized phase 2 on Semaglutide 2.4 mg/week – Phase 3 Trial of Semaglutide

Researchers should not treat them as substitutes for each other based solely on their shared appearance in tissue-repair literature

The Lancet Diabetes & Endocrinology , 2017;5(5):355-366

This leads to various diseases, including atherosclerosis, hypertension, and heart failure

These are pleiotropic effects that go well beyond what you would predict from weight loss or glycemic improvement alone

This dual-action approach can enhance appetite control and metabolic response, potentially leading to even greater weight loss in some patients

2020, found genetically predicted higher IGF-1 was associated with increased colorectal cancer risk specifically, with weaker or inconsistent signals for other cancer sites